IPIX - Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19 https://www.otcmarkets.com/stock/IPIX/news/Innovation-Pharmaceuticals-Receives-Data-Supporting-Brilacidins-Direct-Inhibition-of-SARS-CoV-2-the-Novel-Coronavirus-Re?id=258130